Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular basis and therapeutic targets in prostate cancer: A comprehensive review. | Biomol Biomed | 2023 | 37021836 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation profiling after Ayurveda intervention to bronchial asthmatics identifies differential methylation in several transcription factors with immune process related function. | J Ayurveda Integr Med | 2023 | 37018893 | PubTator, text mining | PubMed |
| ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer. | Sci Adv | 2023 | 37018402 | PubTator, text mining | PubMed |
| Comparative oncology: overcoming human cancer through companion animal studies. | Exp Mol Med | 2023 | 37009802 | PubTator, text mining | PubMed |
| The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors. | Int J Mol Sci | 2023 | 36983010 | PubTator, text mining | PubMed |
| Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging. | Cancers (Basel) | 2023 | 36980602 | PubTator, text mining | PubMed |
| Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families. | Cancers (Basel) | 2023 | 36980580 | PubTator, text mining | PubMed |
| Epigenome-Wide Changes in the Cell Layers of the Vein Wall When Exposing the Venous Endothelium to Oscillatory Shear Stress. | Epigenomes | 2023 | 36975604 | PubTator, text mining | PubMed |
| Potential role of exitron-containing homeobox genes in cancer. | WIREs Mech Dis | 2023 | 36974895 | PubTator, text mining | PubMed |
| HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. | Cell Death Dis | 2023 | 36973255 | PubTator, text mining | PubMed |
| Basal cell carcinoma of the prostate with squamous metaplasia: A case report and literature review. | Front Oncol | 2023 | 36969067 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers for Breast Cancer Metastasis Using Penalized Additive Hazards Regression Model. | Cancer Inform | 2023 | 36968522 | PubTator, text mining | PubMed |
| Metastatic prostate cancer presenting as a posterior mediastinal mass: A rare presentation. | Clin Case Rep | 2023 | 36968347 | PubTator, text mining | PubMed |
| Correlated with better prognosis, CSTA inhibits metastasis of nasopharyngeal carcinoma cells via suppressing AKT signaling through promoting METTL3 degradation. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36963524 | PubTator, text mining | PubMed |
| Scalp Metastasis as an Initial Manifestation of Squamous Cell Carcinoma of the Lung: Case Report of an Extremely Rare Entity. | Cureus | 2023 | 36960245 | PubTator, text mining | PubMed |
| Primary human organoids models: Current progress and key milestones. | Front Bioeng Biotechnol | 2023 | 36959902 | PubTator, text mining | PubMed |
| Systematic assessment of prognostic molecular features across cancers. | Cell Genom | 2023 | 36950380 | PubTator, text mining | PubMed |
| Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer. | Clin Cancer Res | 2023 | 36939530 | PubTator, text mining | PubMed |
| Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 | 36937425 | PubTator, text mining | PubMed |
| First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report. | Front Oncol | 2023 | 36937405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=20